It is suggested that while in some cases sinoatrial block may be ofphysiological origin, it is more often due to sinoatrial disease. The latter group are liable to Adams-Stokes syncope and may have additional atrioventricular conduction abnormalities. The possible mechanisms and treatment of sinoatrial block are discussed relative to the autonomic and pacemaker function abnormalities described.
Sinoatrial block is an uncommon dysrhythmia of unknown mechanism, characterized by the omission of P waves in the setting of a basic regular rhythm (Greenwood and Finkelstein, I964) . It is found incidentally in normal asymptomatic subjects and in some having dizzy spells or syncope. It may occur as an isolated dysrhythmia or in association with sinus bradycardia (Easley and Goldstein, I97I) , tachycardia (Short, 1954) or, sometimes, with atrioventricular conduction disorders.
A group of patients with sinoatrial block has been investigated using autonomic reflex and pharmacological tests of atrial pacemaker function. The aim of the study has been to define the mechanism of the dysrhythmia and to assess its clinical significance in individual subjects.
Subjects and methods
Sixteen healthy adults volunteered as control subjects after full explanation of the nature of the investigation. The age range of the controls was 2i to 68 years (mean: 44 years).
From 987 symptomatic patients referred to the Pacing Unit of this hospital, 47 were found to have recorded evidence of sinoatrial block using the criteria of Greenwoodand Finkelstein (i964). Of these 47, 17 gave their fully informed consent to the investigation. The age range of the patients was i8 to 82 years (mean 60 years).
Patients with fixed-rate pacemakers were excluded.
Those with demand pacemakers were included since their units could be 'switched off' by external means, thus making the underlying rhythm apparent and available for study. For this purpose an external pulse generator was attached to the skin overlying the implanted pacemaker and set to stimulate the skin at a rate greater than the pacemaker takeover rate.
No patient was admitted to the investigation if the sinoatrial block could be related to drug therapy, untreated hypothyroidism, raised intracranial pressure, recent cardiac infarction, or cerebrovascular accident.
A history was obtained from each subject with particular attention to the occurrence and character of syncope. The differentiation of 'vasomotor syncope' from 'Adams-Stokes attacks' can be established from a detailed history or observation and is of great clinical importance. In the vasomotor attack consciousness is lost gradually with dimming of vision, nausea, and subjective feelings of temperature change. The onset of an Adams-Stokes attack is more abrupt though there may be time for the subject to subside into a chair or onto the floor before losing consciousness. The essential feature of the attack is the absence of the pulse, and flushing on recovery is often remembered by the patient as well as observed by witnesses.
All subjects were examined and weighed before investigation. Those 
(b) Drug tests
Following the reflex tests, with the patient supine and at rest, intravenous bolus injections of the following drugs were made through a normal saline infusion into an antecubital vein.
(i) S ,ug isoprenaline per 70 kg body weight (BW) (using a freshly prepared solution in 2 ml vials, 5 mg/ml containing sodium metabisulphate).
(ii) 0.02 mg atropine sulphate per kg BW.
(iii) o.8 mg prostigmine per 70 kg BW, given 20 minutes following the dose of atropine.
The drugs were given in the order shown and flushed in with not more than 2 ml normal saline. A period of approximately io minutes elapsed between the doses of isoprenaline and atropine while the heart rate retumed to previous control level. Only one dose of each drug was given.
The doses given were chosen to give an easily measurable response without resulting in undue side effects. The dose of prostigmine was suggested by the work of Fielder et al. (I969) .
Electrocardiograms were recorded continuously, from I0 seconds before to i minute after the dose of isoprenaline. The same procedure was followed for the atropine dose but further electrocardiograms (5 to io second strips) were taken every 5 minutes until 20 minutes after the injection. Twenty minutes after the atropine injection the dose of prostigmine was given. After the dose of prostigmine, i0-second recordings were made every minute for I0 minutes.
The electrocardiograms were analysed for atrial rate with a standard rate calculating ruler. The control rates were taken as an average of five estimates during the control period before each dose, only regular sinus rhythm being acceptable during this period. In the case of both atropine and isoprenaline the atrial rate was analysed with one estimate at every 3-second intervals during the first minute. This was estimated from a gradient drawn through the steepest four points on the response curve.
Results
The clinical features of the patients are presented in Table i .
The electrocardiographic features are presented in Table 2 . (i) Isoprenaline responses In the control subjects the increase above control resting rate was at least 22 beats a minute, but in 9 of the patients with sinoatrial block this increase in rate was not achieved. Similarly the acceleration of rate was less than in controls in 6 of the patients.
Both the increase in rate and the acceleration of rate in response to isoprenaline were reduced in the patients with sinoatrial block compared with the controls (P < o.oi).
During (I964) found that two-thirds of the patients had some evidence of cardiac pathology or drug toxicity associated with the arrhythmia. Cardiac ischaemia and previous rheumatic fever were found to be major causes. One-third of the patients were fit young adults thought to be clinically normal. The natural occurrence of sinoatrial block is suggested by the finding of only 5 asymptomatic cases in an electrocardiographic survey of 67375 American servicemen aged 20 to 24 years (Hiss, Averill, and Lamb, I960). In the series of I7 patients with sinoatrial block reported here, 6 had evidence of ischaemic heart disease, and i of rheumatic valve disease. There was no evidence of heart disease in the other patients though i gave a definite history of rheumatic fever and i had treated myxoedema.
The mechanism of sinoatrial block has been in question (Scherf, I969) since it was described by Wenckebach (I907). There is no evidence that true 'block' occurs at the sinoatrial nodal level. On the basis of experimental work (Eyster and Meek, 1917; Scherf, I946) it seems unlikely that a pathological process could reversibly block the transmission of impulses from the sinoatrial node to atrium. The term sinoatrial 'block' may, therefore, be unjustified, a view supported by the present work which suggests defective atrial pacemaker function in most of the patients. The sinoatrial node in sinoatrial block possibly produces impulses which are regular but at times subthreshold and unable to conduct to the atrium. This mechanism, previously suggested by by Resnik (I925), would explain the omission of an exact number of cycles in otherwise regular rhythm -a criterion that has been used to define sinoatrial block (Greenwood and Finkelstein, I964) .
The majority of patients investigated were shown to have defective sinoatrial function suggesting that some pathological process in the atrium was responsible for the dysrhythmia in most cases. The pathological process in the atrium has presumably to be widespread to account for the lack of takeover by surrounding atrial pacemakers. Additional disease of the atrioventricular conducting tissue might account for the lack of atrioventricular nodal take. over and subsequent asystole in some cases. It is possible that diminished pacemaker function in the atrioventricular node and lower sites might be present before conduction defects are apparent with routine electrocardiography. 
